Volume 15, Issue 11 pp. 1191-1198

Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia

A. H. Mackey

A. H. Mackey

Department of Surgery, University of Auckland, Auckland, New Zealand

Search for more papers by this author
F. Miller

F. Miller

Children’s Therapy, Starship Children’s Hospital, Auckland, New Zealand

Search for more papers by this author
S. E. Walt

S. E. Walt

Department of Sport and Exercise Science, University of Auckland, Auckland, New Zealand

Search for more papers by this author
M.-C. Waugh

M.-C. Waugh

The Children’s Hospital at Westmead, New South Wales, Australia

Search for more papers by this author
N. S. Stott

N. S. Stott

Department of Surgery, University of Auckland, Auckland, New Zealand

Search for more papers by this author
First published: 06 October 2008
Citations: 26
Anna Mackey, Department of Surgery, University of Auckland, Private Bag 92019, Auckland, New Zealand (tel.: +64 9 3737599, ext 85387; fax: +64 9 3766159; e-mail: [email protected])

Abstract

Background and purpose: To examine whether three-dimensional (3-D) kinematic analysis can detect changes in upper limb tasks (reach and hand-to-mouth) in children with hemiplegia, following upper limb botulinum toxin A injections.

Methods: Ten children with hemiplegic cerebral palsy (7 males, 3 females, aged 9–17 years). Subjects received botulinum toxin A (Botox) injections into elbow forearm muscles combined with 6 weeks of occupational therapy. Participants completed a 3-D kinematic analysis of two upper limb tasks, Melbourne Assessment of Unilateral Upper Limb Function and modified Ashworth scores measured at baseline, 2, 6 and 12 weeks post-injection.

Results: Post-injections, elbow flexor muscle tone was reduced for 12 weeks (p < 0.05). Group differences in active range of motion during 3-D analysis tasks could not be demonstrated at any time post-intervention. However, individual analyses found that at 2 weeks post-injection, three subjects had >15 degrees increases in active elbow extension and six subjects showed an increase of >25 degrees in forearm supination during performance of the reach and hand-to-mouth tasks, respectively.

Conclusions: 3-D kinematics can detect changes in active movements during functional tasks following botulinum toxin A injections, suggesting this could be a potential objective outcome measure in a clinical trial.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.